ApprovedFDA approvedATC · H03AA02Rx · Prescription only (Rx)

Liothyronine (T3)

Synthetic T3 triiodothyronine (Cytomel). Specific indications (myxedema coma, T4-conversion impairment, MDD augmentation). NOT routine choice.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Liothyronine (T3) vial

WHAT IS LIOTHYRONINE (T3)?

Detailed overview

Liothyronine is the synthetic form of active T3 hormone (Cytomel, FDA 1956). NOT routine in hypothyroidism – levothyroxine (T4) provides physiologic T3 via endogenous deiodinase conversion. Specific indications: (1) MYXEDEMA COMA emergency treatment (fast-onset T3 IV), (2) subjective symptomatic hypothyroidism on levothyroxine with normal TSH (suspected T4-T3 conversion impairment, ETA 2012 PMID 24782999 debate), (3) MDD augmentation (Cooper-Kazaz 2007 PMID 17888912 treatment-resistant MDD), (4) DTC suppression post-thyroidectomy with fast onset. Short half-life (1 day vs T4 7 days), so 2-3x/day dosing required, harder to achieve stable levels.

Data console

Lab data

/lab/molecular-data.jsonLIVE
> ATC codeH03AA02
> PrescriptionPrescription only (Rx)
> MechanismDirect T3 replacement, NOT requiring T4 → T3 peripheral dei…
> Half-life~1 day (much shorter than T4)
> Onset2-4 h (oral), minutes (IV)
> Bioavailability95% (oral, within 4 hours – FDA Cytomel label)

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Cardiovascular overstimulation: tachycardia, palpitations, atrial fibrillation and angina, especially in elderly or ischemic heart disease. The short half-life makes T3 peaks sharper than with T4.
  • Overdose (iatrogenic hyperthyroidism) symptoms: tremor, sweating, heat intolerance, anxiety, insomnia, weight loss, diarrhea. The 2-3x/day dosing makes stable levels hard to maintain.
  • Long-term over-replacement can cause reduced bone mineral density and osteoporosis, especially in postmenopausal women (under TSH suppression).
  • Transient hair loss, headache, muscle cramps or fatigue at the start of treatment while thyroid status adjusts.
  • Allergic/hypersensitivity reactions to tablet excipients (rash, urticaria); the hormone itself is rarely allergenic.
  • May increase insulin or oral antidiabetic requirements and worsen glycemic control in diabetes.

Contraindications · 1

  • Acute MI, untreated adrenal insufficiency, thyrotoxicosis

Related Pharmaceuticals

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Liothyronine (T3)?

Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.